Navigation Links
New FDA approved pre-surgical treatment for cleft lip/palate
Date:12/12/2013

OTTAWA, Dec. 12, 2013 /PRNewswire/ -- Parents and healthcare professionals who care for more than 4,000 cleft lip/palate babies born each year in the U.S. now have a new non-invasive pre-surgical treatment available that research finds is as effective as the established method, yet significantly less expensive.

The DynaCleft® cleft lip and palate treatment device uses an elastomeric band to bridge the cleft segments. Its elastic core applies controlled forces to both lip and palate, while gently conforming to the baby's mouth to accommodate feeding, crying or smiling. Applied topically shortly after birth, the device slowly guides soft tissues and bone of the cleft lip and palate into a better position for repair, making first cleft surgery easier for both surgeon and baby.

Developed in collaboration with cleft teams, DynaCleft® saves time, money and most importantly, provides greater comfort for the baby. Used together with a simple nasal elevator hand-fashioned from common clinical materials, the new method makes pre-surgical cleft lip and palate treatment accessible to more newborns and greatly reduces the burden of care for parents.

A study published recently in The Cleft Palate-Craniofacial Journal found the clinical effectiveness of this new topical pre-surgical treatment equal to that of the orthodontic appliance widely considered to be the gold standard of pre-surgical treatment for cleft lip and palate. The randomized, prospective study of babies born between 2007 and 2010 with complete unilateral cleft lip and palate compared the results of cleft width reduction and nasal deformity correction between the NAM-Grayson appliance and the new topical method, and concluded that the combination of DynaCleft® with a nasal elevator achieves equivalent results to the NAM (nasoalveolar molding) intra-oral appliance.

Dr. LaQuia Walker, a pediatric dentist with the Riley Hospital for Children at IU Health's Craniofacial Anomalies Team in Indianapolis, says her team uses the DynaCleft® plus nasal elevator method in their protocol because they believe the burden of care on parents of cleft babies is too high with the NAM method. The NAM requires continuous adjustments over a three-to-six month period, so parents must commit to bringing their baby in weekly for custom shaping of the appliance by a specially-trained orthodontist. The time and out-of-pocket expenses required simply to attend appointments can be prohibitive for many families.

"Although NAM therapy is considered to be one of the most effective forms of pre-surgical orthopedics, it is also one of the most costly and time-consuming," says Dr. Walker. "NAM is a labor-intensive technique that requires frequent visits to our craniofacial center over several months. Such requirements can be problematic for many parents who commonly travel great distances as well as having other responsibilities that cannot be put on hold during these first crucial months of the infant's life."

According to the study's lead author Dr. Luis Monasterio, a specialist with more than 40 years experience treating cleft lip and palate babies, this new topical technique may also make babies happier. In the published study, he described the experience of wearing an intra-oral orthodontic appliance from a newborn baby's perspective: "If I was an infant with complete unilateral cleft lip and palate, and soon after my birth someone would place an appliance inside my mouth, a nasal antenna which would obstruct my nasal passage, and cover around my mouth with paper tape, I would certainly not be a happy baby."

The DynaCleft® device, developed by Canica Design Inc. in Ottawa, Ontario is the only FDA, EU and Health Canada-approved medical device designed specifically for the pre-surgical treatment of cleft lip and palate.

For more information (including "before and after" case photos and video) visit www.dynacleft.com.



'/>"/>
SOURCE Canica Design Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Shire Announces that the US Food and Drug Administration has Responded to its Citizen Petition for Adderall XR and has Approved One Abbreviated New Drug Application for Generic Adderall XR
2. Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.
3. Hologic Human Papillomavirus (HPV) High-Risk Test Approved for Use in The Netherlands Population Cervical Screening Programme
4. Life Technologies Acquires Pinpoint Genomics and CLIA-Approved Lung Cancer Test
5. Stem Cell Supplement Approved In Taiwan
6. InkSure Introduces FDA Approved High Security Taggants for Direct Food Contact
7. First FDA approved subcutaneous implantable defibrillator available for patients at risk for sudden cardiac arrest
8. Shares of Oramed Pharmaceuticals Are Approved for Listing on the Nasdaq Capital Market
9. Experienced Surgeon Vs. FDA-Approved Robot
10. SafeCode Drug Technologies to Hire Project Manager to Market FDA Approved Painless Injection Device
11. Roche/Chugais Bitopertin Will Garner Nearly $1.5 Billion in Major-Market Sales in 2022 as the First Approved Treatment for Negative Symptoms in Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... International plc (NASDAQ: ENDP ) will announce its second-quarter ... senior management team will host a conference call and webcast before ... The dial-in number to access the call is U.S./ ... is 45397076. Please dial in 10 minutes prior to the scheduled ... of the call will be available from August 8, 2017 at ...
(Date:7/12/2017)... 2017 CarpalAID is a revolutionary new product that relieves ... Carpal tunnel syndrome affects more than 8 million people a ... of men. The common methods of treating CTS are painful surgery, ... braces or gloves. ... CarpalAID is a clear patch worn on the palm ...
(Date:7/11/2017)... , July 11, 2017  Sysmex America, Inc., ... diagnostic testing equipment as well as middleware information ... way to make quality assurance easier and more ... is well known for the innovation that it ... Monitor elevates quality assurance processes to a new ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... ... ChenMed , a leading provider of value-based care for seniors, today announced ... Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family Medicine at the ... for the UVA Health System, brings 30 years of highly relevant experience to his ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended ... The adjustable beds used in such facilities are specially designed to accommodate patients with ... support. , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM ...
(Date:7/20/2017)... ... July 20, 2017 , ... Vixiar Medical, Inc. , ... systems for monitoring cardiopulmonary diseases, announced today that it has raised seed round ... submissions and fund final engineering and initial production of the Company’s first product, ...
(Date:7/20/2017)... ... July 20, 2017 , ... TCGRx announced ... its existing adherence automation lines. The ATP® Mini and InspectRx® Mini ... TCG’s standard products, but at a size and price point that can help ...
(Date:7/20/2017)... ... July 20, 2017 , ... A budget proposal to switch ... of - living - adjustment (COLA) is a bad deal for older and disabled ... price index (CPI) would grow even more slowly than the conventional one that is ...
Breaking Medicine News(10 mins):